Back to trials
completed
Not Applicable

NCT01752140

A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme

Sponsored by Hospital de Santa Maria, Portugal

Summary

In this study, the investigators aim to determine if the Vienna nomogram increases the detection rate of TRUS-guided prostate biopsies by conducting a prospective randomized study comparing the Vienna nomogram with a 10-core biopsy protocol.

Eligibility Criteria

Inclusion Criteria: * PSA elevation * Abnormal digital rectal examination * Abnormal findings on prostate imaging Exclusion Criteria: * Active urinary tract infection * Documented previous pathological prostatitis * History of urinary retention * Recent lower urinary tract surgery

Locations (1)

Urology Department - Hospital de Santa Maria

Lisbon, Lisbon District, Portugal

Why you can trust this information
Registry sourcesclinicaltrials_gov
Source last updated12/19/2012
Clintriva indexed9/27/2026, 9:24:19 PM
Registry records1
Relationships needing review0

Identity-resolution confidence concerns registry/entity resolution and does not determine clinical eligibility.

Interested in this trial?

Express your interest and we'll connect you with the trial team.

Your selected profile and contact information may be shared with an authorised trial site, sponsor, or Clintriva coordination team for trial contact and pre-screening. Expressing interest does not mean you are eligible or enrolled.

Quick Facts
Start DateJan 1, 2009
CompletionJul 1, 2010
Enrollment0/463
CountryPortugal

Conditions

Prostate Cancer
View on registry
Clintriva
GDPR Controls Mapped HIPAA Safeguards Mapped NHS DSP Controls Mapped SOC 2 Controls Mapped

© 2026 Clintriva. All rights reserved.